Virogin Biotech

Developed of drugs for the treatment of cancer

placeVancouver, British Columbia, Canada calendar_todayFounded 2015 groups56 employees language virogin.com

Innovation

31 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,485 times.

YearFilings
20172
20183
20198
20206
20216
20229
202310
202414
20259
20262

Investor mix

19 investors on record; lead investors include CDH, SDIC, Panlin Capital, Korea Investment Holdings.

Investor typeCountShare
Venture capital947%
Private equity421%
Bank & private debt211%
Other / undisclosed421%
Coming soon